5728-32-5Relevant articles and documents
Hexagonal Boron Nitride Supported N-Heterocyclic Carbene-Palladium(II): A New, Efficient and Recyclable Heterogeneous Catalyst for Suzuki–Miyaura Cross-Coupling Reaction
Antony, Arnet Maria,Kandathil, Vishal,Kempasiddaiah, Manjunatha,Sasidhar,Patil, Shivaputra A.,Patil, Siddappa A.
, p. 1293 - 1308 (2020/10/06)
Abstract: In this study, a new stable and powerful hexagonal boron nitride supported N-heterocyclic carbene-palladium(II) complex (h-BN@NHC-Pd) heterogeneous catalyst was designed and synthesized. The structure of the h-BN@NHC-Pd heterogeneous catalyst was characterized by various techniques such as Fourier transform infrared spectra (FT-IR), ultraviolet–visible spectroscopy (UV–Visible), inductively coupled plasma-optical emission spectroscopy (ICP-OES), energy-dispersive X-ray spectroscopy (EDS), field-emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), X-ray powder diffraction (XRD), thermogravimetric analysis (TGA) and Brunauer–Emmett–Teller surface area analysis (BET). Then catalytic activity of h-BN@NHC-Pd heterogeneous catalyst was studied in the Suzuki–Miyaura cross-coupling reactions between aryl halides and arylboronic acids in aqueous medium at room temperature. The effects of varying solvents, bases, temperature, time and catalytic ratios on the performance of the Suzuki–Miyaura cross-coupling reaction were investigated. Moreover, h-BN@NHC-Pd heterogeneous catalyst could be easily recovered through simple filtration or centrifugation method and could be reused five times without significant loss of its catalytic efficiency. Furthermore, stability of the h-BN@NHC-Pd heterogeneous catalyst after recycling was confirmed through FESEM and FT-IR techniques. The h-BN@NHC-Pd heterogeneous catalyst shows remarkable advantages such as simplicity of operation, excellent yields, short reaction times, heterogeneous nature, easily separable and high stability without leaching. Graphic Abstract: A new stable and powerful hexagonal boron nitride supported N-heterocyclic carbene-palladium(II) complex (h-BN@NHC-Pd) heterogeneous catalyst was designed, synthesized, characterized and catalytic activity was studied in the Suzuki–Miyaura cross-coupling reactions. [Figure not available: see fulltext.]
Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist for Use in Central Nervous System Disease Models
Amaradhi, Radhika,Banik, Avijit,Mohammed, Shabber,Patro, Vidyavathi,Rojas, Asheebo,Wang, Wenyi,Motati, Damoder Reddy,Dingledine, Ray,Ganesh, Thota
, p. 1032 - 1050 (2020/03/10)
Activation of prostanoid EP2 receptor exacerbates neuroinflammatory and neurodegenerative pathology in central nervous system diseases such as epilepsy, Alzheimer's disease, and cerebral aneurysms. A selective and brain-permeable EP2 antagonist will be useful to attenuate the inflammatory consequences of EP2 activation and to reduce the severity of these chronic diseases. We recently developed a brain-permeable EP2 antagonist 1 (TG6-10-1), which displayed anti-inflammatory and neuroprotective actions in rodent models of status epilepticus. However, this compound exhibited moderate selectivity to EP2, a short plasma half-life in rodents (1.7 h) and low aqueous solubility (27 μM), limiting its use in animal models of chronic disease. With lead-optimization studies, we have developed several novel EP2 antagonists with improved water solubility, brain penetration, high EP2 potency, and selectivity. These novel inhibitors suppress inflammatory gene expression induced by EP2 receptor activation in a microglial cell line, reinforcing the use of EP2 antagonists as anti-inflammatory agents.
Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties
Hansen, Anders H?jgaard,Sergeev, Eugenia,Bolognini, Daniele,Sprenger, Richard R.,Ekberg, Jeppe Hvidtfeldt,Ejsing, Christer S.,McKenzie, Christine J.,Rexen Ulven, Elisabeth,Milligan, Graeme,Ulven, Trond
supporting information, p. 9534 - 9550 (2018/10/24)
Free fatty acid receptor 2 (FFA2/GPR43) is a receptor for short-chain fatty acids reported to be involved in regulation of metabolism, appetite, fat accumulation, and inflammatory responses and is a potential target for treatment of various inflammatory and metabolic diseases. By bioisosteric replacement of the central pyrrolidine core of a previously disclosed FFA2 agonist with a synthetically more tractable thiazolidine, we were able to rapidly synthesize and screen analogues modified at both the 2- and 3-positions on the thiazolidine core. Herein, we report SAR exploration of thiazolidine FFA2 agonists and the identification of 31 (TUG-1375), a compound with significantly increased potency (7-fold in a cAMP assay) and reduced lipophilicity (50-fold reduced clogP) relative to the pyrrolidine lead structure. The compound has high solubility, high chemical, microsomal, and hepatocyte stability, and favorable pharmacokinetic properties and was confirmed to induce human neutrophil mobilization and to inhibit lipolysis in murine adipocytes.